These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Comparative effects of sodium pyrithione evoked intracellular calcium elevation in rodent and primate ventral horn motor neurons. Knox RJ; Keen KL; Luchansky L; Terasawa E; Freyer H; Barbee SJ; Kaczmarek LK Biochem Biophys Res Commun; 2008 Feb; 366(1):48-53. PubMed ID: 18053804 [TBL] [Abstract][Full Text] [Related]
44. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481 [TBL] [Abstract][Full Text] [Related]
45. Percutaneous absorption of hydrocortisone increases with long-term administration. In vivo studies in the rhesus monkey. Wester RC; Noonan PK; Maibach HI Arch Dermatol; 1980 Feb; 116(2):186-8. PubMed ID: 6766708 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey. Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic studies following systemic and topical administration of [14C]bifonazole in man. Patzschke K; Ritter W; Siefert HM; Weber H; Wegner LA Arzneimittelforschung; 1983; 33(5):745-50. PubMed ID: 6683553 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic profile of [14C]flutrimazole following single topical application in normal and scarified skin of healthy volunteers. Duchène P; Papalexiou P; Ramis J; Izquierdo I; Houin G Arzneimittelforschung; 1992 Jun; 42(6):861-3. PubMed ID: 1418047 [TBL] [Abstract][Full Text] [Related]
50. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats. Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446 [TBL] [Abstract][Full Text] [Related]
51. Topical bioavailability of a potential anti-acne agent (SC-23110) as determined by cumulative excretion and areas under plasma concentration time curves. Wester RC; Noonan PK J Invest Dermatol; 1978 Feb; 70(2):92-4. PubMed ID: 146056 [TBL] [Abstract][Full Text] [Related]
52. Absorption, metabolism, and disposition of [14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in minipigs following oral, intravenous, and dermal administration. Tse FL; Laplanche R Pharm Res; 1998 Oct; 15(10):1614-20. PubMed ID: 9794506 [TBL] [Abstract][Full Text] [Related]
53. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro. Vejnovic I; Huonder C; Betz G Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203 [TBL] [Abstract][Full Text] [Related]
54. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy. Gupta AK; Pillai R J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730 [TBL] [Abstract][Full Text] [Related]
55. [Distribution of Luliconazole in Nail Plate by In Vitro Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution]. Shimamura T; Miyamae A; Arai M; Minemura A; Nozawa A; Kubota N Med Mycol J; 2016; 57(1):J19-25. PubMed ID: 26936348 [TBL] [Abstract][Full Text] [Related]
56. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space. Elewski BE; Pollak RA; Pillai R; Olin JT J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
58. Transungual drug delivery: current status. Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318 [TBL] [Abstract][Full Text] [Related]
59. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach. Kircik LH J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788 [TBL] [Abstract][Full Text] [Related]
60. Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases. Baswan S; Kasting GB; Li SK; Wickett R; Adams B; Eurich S; Schamper R Mycoses; 2017 May; 60(5):284-295. PubMed ID: 28098391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]